Insmed, Inc. (INSM)
144.61
+5.11
(+3.66%)
USD |
NASDAQ |
Mar 16, 16:00
144.61
0.00 (0.00%)
After-Hours: 20:00
Insmed EPS Diluted (Quarterly) : -1.538 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Madrigal Pharmaceuticals, Inc. | -2.566 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Biogen, Inc. | -0.3333 |
| Amicus Therapeutics, Inc. | 0.0054 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -328.48M |
| Revenue (Quarterly) | 263.84M |
| Total Expenses (Quarterly) | 592.33M |
| Enterprise Value | 29.40B |
| Gross Profit Margin (Quarterly) | 82.51% |
| Profit Margin (Quarterly) | -124.5% |
| Earnings Yield | -4.43% |
| Normalized Earnings Yield | -3.830 |